Evidence map›Paper›PMID 29957061›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

Novel noncanonical regulation of soluble VEGF/VEGFR2 signaling by mechanosensitive ion channel TRPV4.

Anantha K Kanugula, Ravi K Adapala, Priya Midha, Holly C Cappelli, J Gary Meszaros, Sailaja Paruchuri, William M Chilian, Charles K Thodeti

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Management of experimental trabeculectomy filtering blebs via crosslinking of the scleral flap inhibited vascularization.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Article
  6. Review
  7. Studying Angiogenesis Using Matrigel In Vitro and In Vivo.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  8. Article
  9. Ion Channels in Gliomas-From Molecular Basis to Treatment.International journal of molecular sciences · 2023
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Tumor-Derived Extracellular Vesicles Induce Abnormal AngiogenesisFrontiers in bioengineering and biotechnology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Anantha K KanugulaDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA.
Ravi K AdapalaSchool of Biomedical Sciences, Kent State University, Kent, Ohio, USA; and.
Priya MidhaDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA.
Holly C CappelliSchool of Biomedical Sciences, Kent State University, Kent, Ohio, USA; and.
J Gary MeszarosSchool of Biomedical Sciences, Kent State University, Kent, Ohio, USA; and.
Sailaja ParuchuriDepartment of Chemistry, University of Akron, Akron, Ohio, USA.
William M ChilianSchool of Biomedical Sciences, Kent State University, Kent, Ohio, USA; and.
Charles K ThodetiDepartment of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA.
Kent State University · USNortheast Ohio Medical University · USUniversity of Akron · US

Funding

The critical role of the coronary microcirculation in heart failureR01HL135024 · NHLBI · NORTHEAST OHIO MEDICAL UNIVERSITY · PI CHILIAN, WILLIAM M · 2017 to 2020
$1.7M
What mechanisms underlie coronary collateral growth?R01HL135110 · NHLBI · NORTHEAST OHIO MEDICAL UNIVERSITY · PI CHILIAN, WILLIAM M, YIN, LIYA · 2017 to 2020
$1.7M
Mechanotransduction in myocardial adaptation to ischemiaR01HL119705 · NHLBI · NORTHEAST OHIO MEDICAL UNIVERSITY · PI THODETI, CHARLES K · 2015 to 2018
$1.5M
Integration of Mechanical and Soluble Signaling in Tumor AngiogenesisR15CA202847 · NCI · NORTHEAST OHIO MEDICAL UNIVERSITY · PI THODETI, CHARLES K · 2016 to 2016
$453k
Post-Infarction Remodeling in the Diabetic MyocardiumR15HL106442 · NHLBI · NORTHEAST OHIO MEDICAL UNIVERSITY · PI MESZAROS, J GARY, THODETI, CHARLES K · 2012 to 2012
$444k
INTEGRATIVE ANALYSIS OF CORONARY ADAPTATIONS TO ISCHEMIAR01HL059448 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI CHILIAN, WILLIAM M · 1998 to 2000
$58k
NCI NIH HHS R15 CA202847NHLBI NIH HHS R01 HL059448NHLBI NIH HHS R01 HL119705NHLBI NIH HHS R01 HL135024NHLBI NIH HHS R01 HL135110NHLBI NIH HHS R15 HL106442
6 · The paper itself

Abstract

VEGF signaling via VEGF receptor-2 (VEGFR2) is a major regulator of endothelial cell (EC) functions, including angiogenesis. Although most studies of angiogenesis focus on soluble VEGF signaling, mechanical signaling also plays a critical role. Here, we examined the consequence of disruption of mechanical signaling on soluble signaling pathways. Specifically, we observed that small interfering RNA (siRNA) knockdown of a mechanosensitive ion channel, transient receptor potential vanilloid 4 (TRPV4), significantly reduced perinuclear (Golgi) VEGFR2 in human ECs with a concomitant increase in phosphorylation at Y1175 and membrane translocation. TRPV4 knockout (KO) ECs exhibited increased plasma membrane localization of phospho-VEGFR2 compared with normal ECs. The knockdown also increased phospho-VEGFR2 in whole cell lysates and membrane fractions compared with control siRNA-treated cells. siRNA knockdown of TRPV4 enhanced nuclear localization of mechanosensitive transcription factors, yes-associated protein/transcriptional coactivator with PDZ-binding motif via rho kinase, which were shown to increase VEGFR2 trafficking to the plasma membrane. Furthermore, TRPV4 deletion/knockdown enhanced VEGF-mediated migration in vitro and increased expression of VEGFR2 in vivo in the vasculature of TRPV4 KO tumors compared with wild-type tumors. Our results thus show that TRPV4 channels regulate VEGFR2 trafficking and activation to identify novel cross-talk between mechanical (TRPV4) and soluble (VEGF) signaling that controls EC migration and angiogenesis.-Kanugula, A. K., Adapala, R. K., Midha, P., Cappelli, H. C., Meszaros, J. G., Paruchuri, S., Chilian, W. M., Thodeti, C. K., Novel noncanonical regulation of soluble VEGF/VEGFR2 signaling by mechanosensitive ion channel TRPV4.

Indexed as

Cell MovementMechanotransduction, CellularAnimalsCarcinoma, Lewis LungCell ProliferationEndothelium, VascularHumansMicePhosphorylationSignal TransductionTRPV Cation ChannelsTumor Cells, CulturedVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2KDR protein, humanTRPV4 protein, humanTRPV Cation ChannelsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2VEGFA protein, humanangiogenesisendothelial cellphosphorylation

Identifiers

PMID29957061
PMCPMC6355071
OpenAlexW2810377515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.